Kyle has over 16 years of multi organizational investment experience and is an accomplished money manager. He brings experience from established industry players such as Cadiz Asset Management, Prescient Securities and Symmetry where he occupied portfolio management roles in the absolute return space.

The Sygnia Health Innovation Global Equity Fund is a global–equity–general portfolio that seeks to deliver long-term capital growth by investing in predominantly foreign, financially sound equity securities, preference shares, property-related assets, fixed income securities and assets in liquid form, regardless of whether such securities, instruments or assets are listed or unlisted.
As a global healthcare unit trust, the fund provides South African investors with exposure to a global, uncorrelated, thematic growth sector that helps hedge medical liabilities; it also provides ESG principles. The fund offers exposure to key health companies and the accelerated earnings growth cycle they aim to achieve. The portfolio may hold a variety of securities but focuses on companies with direct or indirect exposure to the healthcare sector, which may include pharmaceutical, biotechnology, nanotechnology, information technology, nutrition, well-being and fitness, genetic engineering, medical robotics, nano-microbot and medical 3D-printing technologies. The underlying portfolio is actively managed in terms of sector and geographical allocation.